The Christie NHS FT Annual Report & Accounts 2019-20

The Christie NHS Foundation Trust Annual Report & Accounts 2019-20

Clinical audit of our services provides data on the effectiveness and outcomes of care directly provided by The Christie. The audit programme is approved by the Board of directors and the outcomes of individual audits monitored by the clinical audit committee. Survival rates for 30 days post chemotherapy treatment, 90 days post radical radiotherapy treatment and 30 days post palliative radiotherapy treatment.

Final chemotherapy 30 day survival rate

100.00%

99.50%

99.00%

98.50%

98.00%

Radical XRT 90 day survival rate

93.00% 94.00% 95.00% 96.00% 97.00% 98.00% 99.00% 100.00%

84